arrow
F

Filip K. Knop

University of Copenhagen
H指数:90
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A short-term randomized clinical trial testing feasibility of and physiological responses to a Ruminococcus torques strain in healthy overweight humans

一项短期随机临床试验,测试鲁米诺球菌鲁米诺科鲁斯菌株在健康超重人群中的可行性及生理反应

2026-07-160
OA
Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic–hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study

生长抑素受体2拮抗作用对长期1型糖尿病成年男性和女性在超胰岛素血症正常-低血糖葡萄糖钳夹过程中胰高血糖素代偿调节的影响:一项随机交叉1期研究

2026-05-210
OAAI
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models

花生四烯酰-牛磺酸在人类MASLD中升高,并在临床前模型中保护肝脏脂肪变性和炎症

2026-05-090
OAAI
Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo-Controlled, Double-Blind, Crossover Study

静脉注射催产素对肥胖个体自由进食量或餐后血浆葡萄糖浓度无影响:一项随机、安慰剂对照、双盲、交叉研究

2026-03-100
OAAI
Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial

达匹鲁肽(Dapiglutide),一种GLP-1和GLP-2受体双重激动剂,用于肥胖症:一项随机、双盲、安慰剂对照的平行组概念验证试验

2026-02-210
OAAI
Effects of empagliflozin in patients at risk of heart failure: the empire prevent metabolic trial

恩格列净在心力衰竭高风险患者中的疗效:EMPIRE PREVENT代谢试验

2026-02-010
PRE
Glucocorticoid-induced changes of the gut microbiota and metabolic markers in healthy young men: Outcome of a randomized controlled trial

糖皮质激素诱导的肠道微生物群和代谢标志物变化:一项随机对照试验的结果

2025-11-100
OAAI
Five years liraglutide treatment improves glucose tolerance in women with previous gestational diabetes mellitus-Results from a randomised controlled trial

五年利拉鲁肽治疗改善了既往妊娠期糖尿病女性的葡萄糖耐量——随机对照试验结果

2025-11-010
PRE
Acute effects of GIP and GLP-1 receptor antagonism in totally pancreatectomized individuals: A randomized double-blind, placebo-controlled crossover study

GIP和GLP-1受体拮抗作用在完全胰腺切除个体中的急性效应:一项随机双盲、安慰剂对照交叉研究

2025-10-100
PRE